EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Emergency use authorization of medicines: History and ethical dilemma

Mamta Bishnoi, Aniket Sonker

Perspectives in Clinical Research · 2023-04 · 14 (2) · 49-55

DOI: 10.4103/picr.picr_149_22 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Perspectives in Clinical Research, online erschienen am 13.04.2023. Verfasst von Mamta Bishnoi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Faculty of Life Sciences, Gurugram University, Gurugram, Haryana, India. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The regulatory approval process of the United States Food and Drug Administration and European Union is the most demanding and challenging worldwide. They have the provision of the expedited approval pathways, i.e., “Emergency use authorizations” and “Conditional marketing authorizations,” respectively, to give approval to novel therapeutics agents during emergency situations. India, firstly formalized the accelerated pathway named “Accelerated Approval Process” as per the New Drugs and Clinical Trials rule 2019 to address unmet medical needs that was implemented by the Central Drug Standard Control Organization to approve the novel therapeutics agents during COVID-19. Hence, our aim is to understand and compare the different emergency approval processes in the world, their underlined claims and conditions with the list of approved products under this concept. All the information collected and analyzed from different official websites of regulatory bodies. In this review, we have enlightened on all these processes with their few approved products.

Schlagwörter

Stichwörter der Autor:innen

Biologicsconditional marketing authorizationsemergency approvalrestricted use in emergency authorizationvaccines

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Faculty of Life Sciences, Gurugram University, Gurugram, Haryana, India.
  • Department of Pharmaceutics, Delhi Pharmaceutical Sciences and Research University, New Delhi, India.

Zitieren

APA

Bishnoi, M., & Sonker, A. (2023). Emergency use authorization of medicines: History and ethical dilemma. Perspectives in Clinical Research, 14(2), 49-55. https://doi.org/10.4103/picr.picr_149_22

Vancouver

Bishnoi M, Sonker A. Emergency use authorization of medicines: History and ethical dilemma. Perspectives in Clinical Research. 2023;14(2):49-55. doi:10.4103/picr.picr_149_22

BibTeX
@article{Bishnoi2023,
  author = {Bishnoi, Mamta and Sonker, Aniket},
  title = {Emergency use authorization of medicines: History and ethical dilemma},
  journal = {Perspectives in Clinical Research},
  year = {2023},
  volume = {14},
  number = {2},
  pages = {49--55},
  doi = {10.4103/picr.picr_149_22}
}
Kostenlos starten →